1 min to read News Posted on January 28, 2023 London-listed SPAC targets merger with chronic disease drug developer Istesso – Sky News London-listed SPAC targets merger with chronic disease drug developer Istesso Sky News Source: London-listed SPAC targets merger with chronic disease drug developer Istesso – Sky News share tweet share SPAC Promoters Lost $1B+ in 2022, and There’s More Pain to Come – 24/7 Wall St.By the Numbers: Four Practices Big Law Firms Need to Power 2023 – Bloomberg LawWhy Buy a SPAC Before It Identifies a Target?What Will Crypto SPACs Look Like in 2023? Tags: SPACs